Related Experiment Video
Updated: Dec 8, 2025

Murine Excisional Wound Healing Model and Histological Morphometric Wound Analysis
Published on: August 21, 2020
The role of Smad7 in cutaneous wound healing
Min-Feng Wu1, Qing-Yu Zeng2, Jian-Hua Huang1
1Department of Dermatology, Huadong Hospital, Fudan University, Shanghai, China.
Abstract:
Chronic refractory wounds are generally caused by local tissue defects and necrosis, and they are characterized by delayed wound healing as well as high recurrence, which seriously affects life quality. However, effective therapeutics to treat wounds are currently unavailable. Therapy primarily aims to accelerate generation of granulation tissue and decrease recurrence. The pathogenesis of chronic refractory wounds is closely related to multiple complex signaling pathways and a series of cytokines. Among these signaling pathways, TGF-β/Smad7 axis plays a critical role. Specifically, Smad7 is an antagonist of TGF-β that inhibits activation of TGF-β. Moreover, Smad7 promotes wound healing by regulating cytokines and controlling growth, differentiation and apoptosis of cells, which may be exploited to cure the disease. This review aims to reveal the exact functions and mechanisms of Smad7 in regulation of wound healing.
Insights
Smad7, an antagonist of transforming growth factor-beta (TGF-β), promotes chronic wound healing by regulating cell growth and cytokines. Understanding Smad7
Area of Science:
- Regenerative Medicine
- Molecular Biology
- Dermatology
Background:
- Chronic refractory wounds exhibit delayed healing and high recurrence due to tissue defects and necrosis.
- Current therapeutics lack efficacy, necessitating novel approaches to accelerate granulation and reduce recurrence.
- The pathogenesis involves complex signaling pathways, notably the transforming growth factor-beta (TGF-β)/Smad7 axis.
Purpose of the Study:
- To elucidate the precise functions and mechanisms of Smad7 in regulating wound healing.
- To explore Smad7's potential as a therapeutic target for chronic wounds.
Main Methods:
- Literature review focusing on the TGF-β/Smad7 signaling pathway in wound healing.
- Analysis of Smad7's role as a TGF-β antagonist.
- Examination of Smad7's influence on cytokines, cell growth, differentiation, and apoptosis.
Main Results:
- Smad7 acts as a critical antagonist of TGF-β, inhibiting its activation.
- Smad7 positively regulates cytokines essential for wound repair.
- Smad7 controls cellular processes including growth, differentiation, and apoptosis, thereby promoting healing.
Conclusions:
- The TGF-β/Smad7 axis is pivotal in chronic wound healing.
- Smad7 demonstrates significant therapeutic potential for treating refractory wounds.
- Targeting Smad7 offers a promising strategy to accelerate wound healing and prevent recurrence.
More Related Videos
09:06Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.
Published on: March 25, 2020
08:58Using R, Seurat, and CellChat to Analyze a Single-Cell Transcriptomics Dataset of Mouse Skin Wound Healing
Published on: August 1, 2025
Related Concept Videos
TGF - β Signaling Pathway
Clinical Applications of Epidermal Stem Cells
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Canonical Wnt Signaling Pathway